What does elevated procalcitonin (PCT) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated procalcitonin levels strongly indicate a bacterial infection, particularly sepsis, and should prompt immediate initiation of broad-spectrum antibiotics and further diagnostic workup. The most recent and highest quality study, published in 2021 1, suggests that procalcitonin levels can be used to support the diagnosis of bacterial infection in patients with COVID-19, and that elevated levels are associated with an increased risk of bacterial co-infection.

Key Points to Consider

  • Procalcitonin is a useful marker for distinguishing bacterial from viral infections, with levels typically rising rapidly in response to bacterial endotoxins and inflammatory cytokines 1.
  • A procalcitonin level of <0.1 mg/L may indicate a high likelihood of viral infection, whereas levels >0.25 mg/L may indicate a high likelihood of bacterial pneumonia 1.
  • However, the sensitivity and specificity of procalcitonin for detecting bacterial infection can vary, and clinical judgment should always supersede biomarker results in decision-making 1.
  • The 2017 Surviving Sepsis Campaign guidelines suggest that measurement of procalcitonin levels can be used to support shortening the duration of antimicrobial therapy in sepsis patients, and to support the discontinuation of empiric antibiotics in patients who initially appeared to have sepsis but subsequently have limited clinical evidence of infection 1.

Recommendations

  1. Start broad-spectrum antibiotics without delay in patients with elevated procalcitonin levels and suspected bacterial infection, considering a combination like piperacillin-tazobactam 4.5g IV every 6 hours plus vancomycin 15-20 mg/kg IV every 8-12 hours (adjusted based on renal function).
  2. Obtain blood cultures before starting antibiotics, if possible, but do not delay treatment.
  3. Assess for signs of organ dysfunction and initiate supportive care as needed (e.g., IV fluids, vasopressors, oxygen).
  4. Identify and control the source of infection (e.g., drain abscesses, remove infected devices).
  5. Monitor procalcitonin levels every 24-48 hours to assess treatment response and guide antibiotic duration.
  6. Consider discontinuing antibiotics when procalcitonin decreases by 80% from its peak or falls below 0.5 ng/mL.

From the Research

Elevated Procalcitonin (PCT) Indications

Elevated procalcitonin (PCT) levels are associated with several clinical indications, including:

  • Bacterial infections, as opposed to viral infections 2, 3, 4, 5, 6
  • Severity of disease, with higher levels indicating more severe illness 2, 4
  • Sepsis and septic shock, with PCT levels correlating with the severity of sepsis 2, 4, 6
  • Infection characteristics, such as the site of infection, microbial agent, and presence of bacteremia 4
  • Organ dysfunction, with PCT levels correlating with the degree of end-organ dysfunction 4

Clinical Utility of PCT

The clinical utility of PCT lies in its ability to:

  • Guide antibiotic treatment, with PCT-guided antibiotic stewardship reducing antibiotic exposure and associated side effects 3, 5, 6
  • Differentiate between bacterial and non-bacterial infections, particularly in respiratory illness 3, 4
  • Monitor the resolution of infection and guide decisions regarding early termination of antibiotic treatment 3, 5
  • Provide invaluable information when viewed as one piece of a clinical puzzle, taking into account preexisting comorbid conditions and clinical scenarios 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Uses of Procalcitonin as a Biomarker in Critical Care Medicine.

Infectious disease clinics of North America, 2022

Research

Procalcitonin in special patient populations: Guidance for antimicrobial therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.